Nuveen’s Ardent Health ARDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$420K Sell
42,647
-25,653
-38% -$243K ﹤0.01% 3345
2026
Q1
$585K Buy
68,300
+37,614
+123% +$337K ﹤0.01% 2779
2025
Q4
$271K Sell
30,686
-294,793
-91% -$3.41M ﹤0.01% 3071
2025
Q3
$4.31M Sell
325,479
-111,584
-26% -$1.4M ﹤0.01% 1980
2025
Q2
$5.97M Hold
437,063
– – ﹤0.01% 1794
2025
Q1
$6.01M Buy
437,063
+267,588
+158% +$3.91M ﹤0.01% 1826
2024
Q4
$2.89M Buy
169,475
+116,610
+221% +$2.02M ﹤0.01% 2228
2024
Q3
$972K Buy
+52,865
New +$934K ﹤0.01% 2778

Other funds holding ARDT

Nuveen's ARDT Position: Q2 2026 in Review

Nuveen reduced its Ardent Health (ARDT) stake by 38% in Q2 2026, selling an estimated $243K and leaving 42,647 shares worth $420K. The position accounts for ﹤0.01% of the portfolio, ranked #3345.

Nuveen first reported a position in ARDT in Q3 2024 and has held it in 8 quarters since. The position peaked at $6.01M in Q1 2025. 138 funds tracked by Wall St. Rank hold ARDT as of Q2 2026.

  • Nuveen held 42,647 shares of Ardent Health worth $420K as of Q2 2026.
  • Nuveen sold 25,653 Ardent Health shares in Q2 2026, an estimated $243K.
  • Ardent Health made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #3345 holding.
  • Nuveen first reported a position in Ardent Health in Q3 2024 and has held it in 8 quarters since.
  • Nuveen's Ardent Health position peaked at $6.01M in Q1 2025.
  • 138 funds tracked by Wall St. Rank held Ardent Health as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.